Retour sur lavenir.net
   UMICORE 17.600 € (-0,17 %)     EVS BROADC.EQUIPM. 36.550 € (+0,27 %)     SEQUANA MEDICAL 0.522 € (+5,14 %)     XIOR 27.650 € (-0,54 %)     GBL 80.700 € (-0,92 %)     SOFINA 226.000 € (-0,35 %)     BARCO 9.425 € (-3,23 %)     AEDIFICA 73.600 € (-0,81 %)     MELEXIS 65.300 € (+2,75 %)     ACKERMANS V.HAAREN 279.200 € (-0,64 %)     AB INBEV 62.580 € (-2,31 %)     ELIA GROUP 137.900 € (-0,93 %)     AGEAS 68.600 € (+0,88 %)     ARGENX SE 686.400 € (-3,00 %)     KBC ANCORA 78.900 € (-1,00 %)     KINEPOLIS GROUP 30.400 € (+0,66 %)     BANQUP GROUP 2.740 € (+3,79 %)     WERELDHAVE BELGIUM 53.600 € (-1,83 %)     SOLVAY 27.360 € (-1,72 %)     UNIFIEDPOST GROUP 2.740 € (+3,79 %)     BEKAERT 41.850 € (+0,72 %)     HOME INVEST BE. 19.160 € (-1,84 %)     AZELIS GROUP 10.360 € (+0,78 %)     CIE BOIS SAUVAGE 323.000 € (-0,31 %)     CENERGY 21.160 € (+0,19 %)     DEME GROUP 184.800 € (-0,11 %)     WDP 23.880 € (-1,08 %)     BREDERODE 103.600 € (+0,39 %)     CARE PROPERTY INV. 12.820 € (-0,77 %)     SHURGARD 27.850 € (-0,36 %)     OPTION 6.760 € (-3,43 %)     LOTUS BAKERIES 9 940.000 € (-0,30 %)     D'IETEREN GROUP 182.700 € (-1,14 %)     AGFA-GEVAERT 0.487 € (-0,51 %)     VIOHALCO 14.500 € (0,00 %)     GIMV 48.650 € (+0,41 %)     ECONOCOM GROUP 1.485 € (0,00 %)     KBC 117.750 € (-0,63 %)     COLRUYT 33.140 € (+0,42 %)     FAGRON 23.800 € (-2,26 %)     TESSENDERLO 21.100 € (-0,24 %)     VAN DE VELDE 32.500 € (+0,31 %)     UCB 247.100 € (-4,59 %)     ASCENCIO 50.000 € (-0,79 %)     FLUXYS BELGIUM D 21.500 € (+0,94 %)     JENSEN-GROUP 71.000 € (-0,84 %)     TUBIZE-FIN 214.800 € (-3,33 %)     RECTICEL 10.020 € (-0,99 %)     BPOST 1.882 € (-0,84 %)     CMB.TECH 11.260 € (-1,05 %)     VASTNED 30.100 € (+0,17 %)     BIOTALYS 2.285 € (-1,51 %)     IMMOBEL 21.600 € (+0,93 %)     DECEUNINCK 2.175 € (+0,69 %)     ONTEX GROUP 3.040 € (-3,34 %)     MONTEA 72.200 € (-0,96 %)     RETAIL ESTATES 69.800 € (-2,10 %)     IBA 14.400 € (-0,96 %)     TITAN S.A. 46.740 € (-1,72 %)     ONWARD MEDICAL 2.905 € (-2,02 %)  
   ABEO 8.060 € (+1,51 %)     SAFRAN 282.400 € (-6,80 %)     HOPIUM 0.008 € (-2,44 %)     BE SEMICONDUCTOR 227.900 € (+0,40 %)     GENFIT 8.900 € (-2,41 %)     SHELL PLC 37.695 € (+0,24 %)     STMICROELECTRONICS 37.610 € (+0,90 %)     EXOR NV 70.000 € (-0,28 %)     SANOFI 81.020 € (-1,23 %)     LVMH 486.000 € (-0,93 %)     UMG 20.080 € (-1,47 %)     KERING 243.200 € (-2,01 %)     MR BRICOLAGE 4.670 € (-1,68 %)     CARREFOUR 16.710 € (-0,54 %)     AIRBUS 170.520 € (-1,54 %)     AXA 42.420 € (-0,07 %)     FLEURY MICHON 22.300 € (0,00 %)     AALBERTS NV 31.440 € (-0,69 %)     TIKEHAU CAPITAL 19.200 € (-2,34 %)     FASTNED 29.800 € (+5,11 %)     JCDECAUX 19.230 € (-3,42 %)     ATOS 36.240 € (-2,74 %)     NANOBIOTIX 26.340 € (-5,05 %)     SARTORIUS STED BIO 188.500 € (+0,96 %)     LEGRAND 147.750 € (-0,54 %)     SOITEC 100.750 € (+0,75 %)     ARKEMA 61.600 € (-0,65 %)     CSG 21.040 € (-0,82 %)     ACCOR 44.340 € (-2,27 %)     UNIBAIL-RODAMCO-WE 104.750 € (-0,62 %)     AIR FRANCE -KLM 9.896 € (-3,50 %)     BIOMERIEUX 90.600 € (+0,50 %)     ADOCIA 5.720 € (+16,83 %)     ABN AMRO BANK N.V. 30.200 € (+0,33 %)     MANITOU BF 21.750 € (+1,64 %)     BOLLORE 5.080 € (+1,09 %)     CRCAM ILLE-VIL.CCI 116.120 € (+0,66 %)     CTP 16.100 € (-1,35 %)     GROUPE OKWIND 1.200 € (+36,36 %)     BENETEAU 7.100 € (-1,11 %)     ABIVAX 98.000 € (-2,58 %)     BNP PARIBAS ACT.A 92.140 € (-0,50 %)     BASIC-FIT 31.460 € (-0,57 %)     CIECHARGEURSINVEST 8.500 € (0,00 %)     THALES 247.700 € (-5,92 %)     Coca-ColaEuropacif 82.100 € (-1,20 %)     SPIE 46.460 € (-1,27 %)     TECHNIP ENERGIES 39.420 € (-0,15 %)     SCHNEIDER ELECTRIC 272.100 € (-0,55 %)     ING GROEP N.V. 24.495 € (0,00 %)     ALSTOM 17.050 € (-0,20 %)     GECINA 72.400 € (-0,21 %)     EDENRED 20.620 € (+1,53 %)     BOUYGUES 52.200 € (-0,53 %)     UNILEVER 48.705 € (-1,23 %)     VALEO 11.120 € (-1,20 %)     REXEL 36.750 € (-1,63 %)     ELIS 26.580 € (-0,97 %)     TKH GROUP 42.360 € (-0,33 %)     EURONEXT 146.600 € (-0,07 %)  
News Réglementées
21/04/2026 19:00

Justera Announces CFO Appointments

TORONTO, ON / ACCESS Newswire / April 21, 2026 / Justera Health Inc. (CSE:VTAL)(OTC:SCRSF) ("Justera" or the "Company") is pleased to announce the appointment of Bruce (Hwan) Lee as Chief Financial Officer of the Company, effective April 21, 2026.

The Company notes that Mr. Lee has been appointed to fill the vacancy created by the resignation of former CFO Paul Haber on March 2, 2026. Mr. Lee's appointment is expected to further strengthen the Company's financial leadership, and reporting and internal controls, and support ongoing strategic and corporate development.

Bruce Lee has been in the finance industry including executive positions in technology, education institutes, healthcare, and automobile industries, over two decades. Mr. Lee has experience in financial reporting, operational finance, and corporate strategy. In the past ten years, he worked as a controller in the automobile industry, improving financial visibility and operational efficiency through system implementation, automation, and policy development.

"We are pleased to welcome Mr. Lee to the executive team as Chief Financial Officer. His extensive experience in corporate finance along with his leadership will be instrumental for the Company's objective", said Andrew Ryu, Interim CEO and Chairman of the Company.

About Justera Health

Established in 2020, Justera is a Canadian company focused on health and wellness. Justera's mission is to enhance Canadians overall well-being with diverse solutions catering to individual needs.

For more information about the Company, please refer to the Company's profile on SEDAR+ at www.sedarplus.ca.

For further information:

Investor Relations & Communications
Andrew Ryu, CEO and Chairman
Tel: (416) 901-5611, ext. 201
Email: info@justerahealth.com

Forward-Looking Statements:

CAUTIONARY STATEMENT ON FORWARD-LOOKING INFORMATION

This news release includes "forward-looking information", as such term is defined in applicable securities laws. Forward-looking information includes, without limitation, the success of exploration activities, price outlooks, production expectations and other similar statements concerning anticipated future events, conditions or results that are not historical facts. These statements reflect management's current estimates, beliefs, intentions and expectations; they are not guarantees of future performance. The Company cautions that all forward looking information is inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Company's control. Accordingly, actual future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. All statements are made as of the date of this news release and the Company is under no obligation to update or alter any forward-looking information.

###

SOURCE: Justera Health Ltd.



View the original press release on ACCESS Newswire

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière